DRUG SAFETY
Scope & Guideline
Empowering Healthcare with Cutting-Edge Drug Safety Research
Introduction
Aims and Scopes
- Pharmacovigilance and Drug Safety Monitoring:
This area covers the systematic collection, analysis, and interpretation of data related to adverse drug reactions (ADRs) and other drug-related problems. It aims to improve safety and efficacy in drug use through ongoing monitoring. - Risk Assessment and Management:
Research focusing on identifying, assessing, and managing risks associated with drug therapies, including the development of frameworks for safer medication use in various populations. - Real-World Evidence and Data Analysis:
Utilizing real-world data sources to analyze drug safety outcomes, effectiveness, and patterns of drug usage. This includes studies using electronic health records and spontaneous reporting systems. - Methodological Innovations in Drug Safety Research:
Development of new methodologies and technologies (e.g., machine learning, big data analytics) for signal detection and causal inference in pharmacovigilance. - Patient-Centric Approaches to Drug Safety:
Research that emphasizes the role of patients in pharmacovigilance, including patient-reported outcomes and experiences related to drug safety. - Special Populations and Vulnerable Groups:
Studies focusing on drug safety in specific populations, such as pregnant women, children, and the elderly, to address unique safety concerns and ensure tailored risk management.
Trending and Emerging
- Integration of Artificial Intelligence and Machine Learning:
There is a growing emphasis on the use of AI and machine learning technologies in pharmacovigilance for signal detection, data analysis, and improving reporting accuracy. - Focus on Vaccine Safety and Monitoring:
Following the COVID-19 pandemic, there has been a significant increase in research related to vaccine safety, particularly regarding the monitoring of adverse events associated with COVID-19 vaccinations. - Patient Engagement and Involvement:
Emerging research emphasizes the importance of involving patients in pharmacovigilance processes, including patient-reported outcomes and experiences, to enhance drug safety practices. - Real-World Data Utilization:
The use of real-world data for evaluating drug safety and efficacy is trending, with studies focusing on how these data can inform regulatory decisions and clinical practice. - Polypharmacy and Drug-Drug Interaction Studies:
Research addressing the complexities of polypharmacy and drug-drug interactions is gaining prominence, reflecting the need to understand safety in patients taking multiple medications. - Ethical Considerations in Pharmacovigilance:
Emerging discussions around the ethical implications of pharmacovigilance practices, particularly regarding data privacy and the responsibilities of stakeholders in drug safety.
Declining or Waning
- Traditional Pharmacovigilance Methods:
There is a noticeable decline in the publication of papers focusing solely on traditional pharmacovigilance methods, as newer technologies and data sources are increasingly prioritized. - General Drug Safety Studies Without Specific Contexts:
Research that lacks a specific context or fails to address contemporary issues in drug safety may be receiving less attention, as the emphasis shifts towards studies that are more relevant to current healthcare challenges. - Single-Agent Drug Studies:
Studies focusing solely on the safety of single agents without considering polypharmacy or drug-drug interactions are becoming less prominent, reflecting a broader understanding of the complexities of real-world medication use. - Pharmacovigilance in Low-Resource Settings:
While still important, the specific focus on pharmacovigilance in low-resource settings may be waning as the journal expands its scope to include more global and comprehensive approaches.
Similar Journals
Current Drug Safety
Navigating the Complexities of Pharmacological SafetyCurrent Drug Safety is a distinguished peer-reviewed journal published by Bentham Science Publishers, focusing on the critical intersection of pharmacology and toxicology. With an ISSN of 1574-8863 and an E-ISSN of 2212-3911, this journal serves as a platform for the latest research and advances in drug safety, highlighting the importance of pharmacological assessments and toxicity evaluations in therapeutic development and public health. Reaching a broad international audience from its base in the United Arab Emirates, Current Drug Safety offers an invaluable resource for researchers, professionals, and students interested in the dynamic fields of drug research and safety management. Despite a current Q3 categorization in multiple pharmacology and toxicology quartiles for 2023, the journal continues to strive for excellence in the scholarly community, reflecting its commitment to disseminating high-quality research. While not operating under an open access model, articles can be accessed through institutional subscriptions and other platforms, ensuring valuable insights into drug safety are available to those who need it most.
Ars Pharmaceutica
Championing excellence in pharmaceutical research and innovation.Ars Pharmaceutica is a distinguished open-access journal published by UNIV GRANADA, EDITORIAL, that has been at the forefront of pharmaceutical sciences since its establishment. With ISSN 0004-2927 and E-ISSN 2340-9894, this journal aims to disseminate high-quality research in pharmacology, toxicology, and pharmaceutics, contributing to the advancement of the field. With a historical scope that spans from 1980 to 2017, it has played a pivotal role in shaping the discourse surrounding pharmaceutical science and its intersection with the arts and humanities. Although currently ranked within the 13th percentile in Scopus for Pharmaceutical Science and the 11th percentile for History and Philosophy of Science, Ars Pharmaceutica continues to uphold its commitment to academic excellence and innovation. By providing a platform for open-access research, it encourages collaboration and knowledge sharing among researchers, professionals, and students, thus enhancing the broader understanding of pharmaceutical developments and their societal implications.
Therapeutic Innovation & Regulatory Science
Exploring Innovations at the Intersection of Health and ComplianceTherapeutic Innovation & Regulatory Science, published by Springer Heidelberg, is an esteemed journal that focuses on the intersection of therapeutic innovations and the regulatory frameworks that govern them. Established in 1970 and continuing its legacy of excellence through converged years, this journal plays a crucial role in supplying cutting-edge research, reviews, and discussions that advance understanding in the fields of pharmacology and healthcare regulation. With an impact factor reflective of its rigorous peer-review standards, this journal holds a prestigious Q1 ranking in Pharmacology, Toxicology, and Pharmaceutics (Miscellaneous) for 2023, reflecting its influence and the high quality of its published material. The journal's wide scope also embraces public health and environmental studies, making it an essential resource for researchers and professionals navigating these critical areas. Open access options enhance its visibility and accessibility, ensuring that the latest discoveries and regulatory insights are readily available to a global audience. For those at the forefront of medicinal science and regulatory affairs, Therapeutic Innovation & Regulatory Science is your avenue to understanding pivotal innovations that shape contemporary therapeutic practices.
FUNDAMENTAL & CLINICAL PHARMACOLOGY
Elevating the standards of pharmacological research and clinical application.FUNDAMENTAL & CLINICAL PHARMACOLOGY is a distinguished journal dedicated to advancing the fields of pharmacology and clinical medicine. Published by WILEY, this journal serves as a pivotal platform for researchers, healthcare professionals, and students alike to disseminate innovative research findings and clinical applications. With an impressive history spanning from 1987 to 2024, it has consistently maintained its relevance in the scientific community, evidenced by its Q2 quartile ranking in both Pharmacology and Pharmacology (medical) categories for 2023. The journal's diverse publication range, which includes original research articles, reviews, and clinical studies, helps bridge the gap between fundamental research and practical application in healthcare settings. Although it does not offer open access, its rigorous peer-review process ensures that published content meets the highest scholarly standards, making it a vital resource for those aiming to stay at the forefront of pharmacological sciences.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Transforming Pharmacology Through Rigorous ResearchBritish Journal of Clinical Pharmacology, published by Wiley, is a premier peer-reviewed journal that has been at the forefront of pharmacology research since its inception in 1974. Renowned for its high academic rigor, it stands out with an impressive impact factor that places it in the Q1 quartile within both the general pharmacology and medical pharmacology categories. With a Scopus ranking reflecting its esteemed status—ranked #68 out of 272 in medical pharmacology and #109 out of 313 in pharmacology, toxicology, and pharmaceutics—the journal serves as a critical resource for researchers, clinicians, and students who are keen to explore innovations and advancements in drug therapy. The journal's scope encompasses a wide array of topics, including clinical trials, drug safety, and pharmacokinetics, making it an essential platform for disseminating cutting-edge pharmacological findings. Although it does not offer open access, the stringent selection of articles ensures that only the highest-quality research is published, further contributing to the ongoing discourse in clinical pharmacology.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
Advancing knowledge in pharmacology and public health.Pharmacopidemiology and Drug Safety is a prestigious academic journal published by Wiley, dedicated to exploring the field of pharmacology and epidemiological studies since its inception in 1992. With its ISSN 1053-8569 and E-ISSN 1099-1557, the journal has achieved notable recognition, ranking Q2 in Epidemiology and Q1 in Medical Pharmacology in the 2023 category quartiles. Its Scopus rankings further enhance its reputation, placing it at 105th in the field of pharmacology and at 63rd in epidemiology, reflecting its commitment to publishing high-quality research that informs clinical practices and public health policies. Although it operates under a subscription model rather than open access, Pharmacopidemiology and Drug Safety plays a critical role in disseminating vital knowledge regarding drug safety and effectiveness, making it an essential resource for researchers, professionals, and students looking to stay at the forefront of advancements in the medical field.
INDIAN JOURNAL OF PHARMACOLOGY
Fostering excellence in pharmacology through rigorous inquiry.INDIAN JOURNAL OF PHARMACOLOGY, published by Wolters Kluwer Medknow Publications, is a premier platform dedicated to advancing the field of pharmacology and its related disciplines. With a rich history since its inception in 1978, this journal aims to disseminate high-quality research findings, reviews, and clinical studies that contribute to the global understanding of drug action and therapeutic practices. As a valuable resource for researchers, professionals, and students alike, it operates within the Q3 quartile of the Pharmacology category, positioning itself as an influential contributor in the realm of medical pharmacology. The journal is committed to publishing rigorous scientific inquiry, fostering innovation, and bridging gaps between laboratory research and clinical application. Readers can access its wide-ranging articles to stay informed about the latest advancements in the field, reflecting its crucial role in shaping future pharmacological research and practice.
BRITISH JOURNAL OF PHARMACOLOGY
Pioneering insights into drug mechanisms and therapeutic innovations.British Journal of Pharmacology is a premier, peer-reviewed journal published by Wiley, specializing in the dynamic field of pharmacology. With a robust impact factor, this journal ranks in the top quartile (Q1) for pharmacology according to the 2023 category rankings, emphasizing its significance and reputation among the global scientific community. As an essential resource for researchers, professionals, and students alike, the journal provides a platform for innovative research spanning foundational studies to clinical applications in pharmacology, toxicology, and pharmaceutics. Since its inception in 1966, the journal has consistently contributed to the advancement of pharmacological science, fostering a deeper understanding of drug action mechanisms and therapeutic advancements. Although primarily subscription-based, the British Journal of Pharmacology is committed to disseminating high-quality research that shapes the future of the field.
PHARMAZIE
Your gateway to cutting-edge pharmaceutical research.PHARMAZIE is a prestigious, peer-reviewed journal published by AVOXA-MEDIENGRUPPE DEUTSCHER APOTHEKER GMBH, focusing on the dynamic field of pharmaceutical science since its inception in 1947. With its ISSN 0031-7144 and a current impact factor placing it in the Q2 category of Pharmaceutical Science journals, PHARMAZIE has established itself as a pivotal resource for researchers, practitioners, and students alike. The journal emphasizes the dissemination of high-quality, original research in pharmacology, toxicology, and pharmaceutics, contributing to the advancement of knowledge and innovation in these fields. While currently not open access, the journal maintains a commendable Scopus rank of #94 out of 183 in its category, highlighting its relevance and appeal to the academic community. With a commitment to bridging the gap between research and practical applications, PHARMAZIE plays a crucial role in shaping the future of pharmaceutical practices and policies.
International Journal of Clinical Pharmacy
Advancing Clinical Pharmacy Knowledge for Global ImpactThe International Journal of Clinical Pharmacy, published by Springer, serves as a pivotal platform for advancing research in the fields of Pharmaceutical Science and Pharmacology. This esteemed journal, recognized for its significant impact with an impressive Q1 ranking in Pharmacy and multiple Q2 designations, provides a dedicated space for scholars and practitioners to share innovative findings and methodologies that enhance clinical pharmacy practices. With an international reach and publication spanning from 2011 to 2024, the journal aims to facilitate knowledge exchange among researchers, professionals, and students, ultimately contributing to improved therapeutic outcomes. As an open-access journal, it promotes widespread dissemination of vital research, ensuring that cutting-edge clinical pharmacy knowledge is accessible to all stakeholders in the healthcare continuum.